The Oritavancin Injection, cataloged under National Stock Number 6505-01-714-2492, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Melinta Therapeutics, Llc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-714-2492 |
| Primary Part Number | NDC70842-0140-03 |
| Item Name | Oritavancin Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Melinta Therapeutics, Llc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC70842-0140-03 PRIMARY | Melinta Therapeutics, Llc (USA) |
| Reference | Meaning |
|---|---|
| 1655443 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM239231 | 5/1 Secondary reference Defense Medical Standardization Board |
| ORBACTIV | 5/1 Secondary reference Melinta Therapeutics, Llc |
NSN 6505-01-714-2492 is a Oritavancin Injection, manufactured by Melinta Therapeutics, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-714-2492 has 1 manufacturer part number on file: NDC70842-0140-03 (Melinta Therapeutics, Llc).
Key specifications for NDC70842-0140-03: Special Features: ORITAVANCIN INJECTION 400MG SINGLE DOSE VIALS, 3CT. FOR INTRAVENOUS INFUSION ONLY. STORE AT 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED TO 15 C TO 30 C (59 F TO 86 F) (SEE USP, CONTROLLED ROOM TEMPERATURE (CRT)). STERILE WHITE TO OFF-WHITE LYOPHILIZED POWDER FOR RECONSTITUTION.; Part Name Assigned by Controlling Agency: ORITAVANCIN INJECTION 400MG SINGLE DOSE VIALS, 3CT. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.